Six months to a year is big. $600k revenue growth Q over Q. Contract revenue should start to spike but will hurt margins some.
So they probably need around $4m a Q to turn profit at these cost levels. I am looking at last half of calendar year as being a good barometer as to whether they are on track to being nice little profitable company.
Since financing took place in the $4.5 range, one would hope that is where they are at soon.
The loss of contract manufacturing was what killed PPS. They hinted strongly they replaced it with a larger contract in the end.
I bought at these PPS levels in anticipation 2015 will show growth.
So they probably need around $4m a Q to turn profit at these cost levels. I am looking at last half of calendar year as being a good barometer as to whether they are on track to being nice little profitable company.
Since financing took place in the $4.5 range, one would hope that is where they are at soon.
The loss of contract manufacturing was what killed PPS. They hinted strongly they replaced it with a larger contract in the end.
I bought at these PPS levels in anticipation 2015 will show growth.
Recent BLFS News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/22/2026 10:37:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 11:10:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 11:04:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2026 11:26:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 10:25:55 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 02:06:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:18:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:14:09 PM
- BioLife Solutions Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/07/2026 08:03:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/28/2026 09:12:49 PM
- BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 • PR Newswire (US) • 04/23/2026 08:03:00 PM
- BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase • PR Newswire (US) • 04/21/2026 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 09:29:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 09:29:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 09:29:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 09:19:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:09:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:09:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:08:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:08:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:08:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:08:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 09:08:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/23/2026 08:38:54 PM
